Gregory Y. H. Lip
European Heart Journal · 2006–2021
A researcher in the Science corpus: 24 papers; trusts 0 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Whom Gregory Y. H. Lip trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Gregory Y. H. Lip overall
- Benjamin Letham
- Cynthia Rudin
- Berk Ustun
- Tyler H. McCormick
- Rahul Wadke
- David Madigan
- Stefano Tracà
- Paulus Kirchhof
- Vivek Y. Reddy
- Lieven Billiet
Papers from Gregory Y. H. Lip's perspective
Ordered by how strongly the researchers Gregory Y. H. Lip trusts endorse each paper. Same corpus, a different order for every researcher.
- Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. (Journal of the American Medical Association (JAMA))
- Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation (Circulation)
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
- Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. (Journal of the American Medical Association (JAMA))
- GRADE guidelines: 3. Rating the quality of evidence. (Journal of Clinical Epidemiology)
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. (The Lancet)
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
- Amiodarone versus sotalol for atrial fibrillation. (New England Journal of Medicine)
- Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses (Circulation: Arrhythmia and Electrophysiology)
- Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression (Circulation Research)
Their papers
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) (2021) — 5,988 citations
- [2018 ESC/ESH Guidelines for the management of arterial hypertension]. (2019) — 6,364 citations
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (2017) — 1,163 citations
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) — 779 citations
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) — 4,502 citations
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016) — 2,566 citations
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016) — 719 citations
- Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. (2013) — 1,323 citations
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (2012) — 1,187 citations
- Inflammation in atrial fibrillation. (2012) — 831 citations
- Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012) — 846 citations
- Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 995 citations
- Apixaban in patients with atrial fibrillation. (2011) — 2,210 citations
- Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. (2011) — 1,096 citations
- A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. (2010) — 4,487 citations
- Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort (2010) — 519 citations
- Underuse of oral anticoagulants in atrial fibrillation: a systematic review. (2010) — 954 citations
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) — 3,695 citations
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. (2010) — 6,747 citations
- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. (2009) — 1,042 citations